COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 947: Articles 9461-9470  | Next

The impact of recurrent rapid test strategies on the effectiveness of at-home antiviral treatments for SARS-CoV-2
Menkir, T., Donnelly, C.
10.1101/2022.01.18.22269408 — Posted: 2022-01-21
The Impact of Frequent SARS-CoV-2 Testing on Weekly Case Rates Among Long-Term Care Facilities in Florida
Allan-Blitz, L., Aboabdo, B., Turner, I., Klausner, J. D.
10.1101/2022.01.18.22268929 — Posted: 2022-01-21
The Global case-fatality rate of COVID-19 has been declining disproportionately between top vaccinated countries and the rest of the world
Haider, N., Hasan, M. N., Khan, R. A., McCoy, D., Ntoumi, F., Dar, O., Ansumana, R., Uddin, M. J., Zumla, A., Kock, R. A.
10.1101/2022.01.19.22269493 — Posted: 2022-01-21 Discussion: Onsite
Effectiveness of COVID-19 Vaccines in preventing Infectiousness, Hospitalization and Mortality: A Historical Cohort Study Using Iranian Registration Data During Vaccination program
Mirahmadizadeh, A., Heiran, A., Bagheri Lankarani, K., Serati, M., Habibi, M., Eilami, O., Heiran, F., Moghadami, M.
10.1101/2022.01.18.22269330 — Posted: 2022-01-21
Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves
Lerdsamran, H., Mungaomklang, A., Iamsirithaworn, S., Prasertsopon, J., Wiriyarat, W., Saritsiri, S., Anusorntanawat, R., Siriyakorn, N., Intalapaporn, P., Sirikhetkon, S., Sangsiriwut, K., Dangsakul, W., Sawadpongpan, S., Thinpan, N., Okada, P., Techasuwanna, R., Mongkalangoon, N., Prasert, K., Puthavathana, P.
10.1101/2022.01.18.22269501 — Posted: 2022-01-21
SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria
Kern, A., Kuhlmann, P. H., Matl, S., Ege, M., Maison, N., Eckert, J., von Both, U., Behrends, U., Anger, M., Frühwald, M. C., Gerstlauer, M., Woelfle, J., Neubert, A., Melter, M., Liese, J., Goettler, D., Sing, A., Liebl, B., Hübner, J., Klein, C., COVID Kids Bavaria Consortium
10.1101/2022.01.18.22269445 — Posted: 2022-01-21
Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan
Rizwan, W., Qureshi, A. U., Rana, M. N., Duggal, M. N., Sohaib, M., Sadiq, M.
10.1101/2022.01.18.22268965 — Posted: 2022-01-21
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P. J., Hasan, M. R., Coyle, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R.
10.1101/2022.01.18.22269452 — Posted: 2022-01-21
Testing behaviour may bias observational studies of vaccine effectiveness
Glasziou, P., McCaffery, K. J., Cvejic, E., Batcup, C., Ayre, J., Pickles, K., Bonner, C.
10.1101/2022.01.17.22269450 — Posted: 2022-01-21
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature coding.
Banada, P. P., Green, R., Banik, S., Streck, D., Montalvan, I., Reiss, R., Jones, R., Marras, S., Chakravorty, S., Alland, D.
10.1101/2022.01.18.22269424 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).